XML 91 R64.htm IDEA: XBRL DOCUMENT v3.25.4
Fair Value Measurements - Narrative (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
Aug. 19, 2024
Feb. 26, 2021
shares
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Convertible debt, fair value $ 500 $ 500        
Conversion of notes receivable for common stock   $ 0 $ 10,476 $ 0    
Class of warrant or right, outstanding (in shares) | shares 40 40        
Contingent consideration payment   $ 0 922 1,411    
Warrant, stock split, conversion ratio         0.025  
(Loss) gain on investments:   (16,411) (28,827) (54,827)    
Downward adjustments from observable price changes   2,713 0 1,627    
Impairment loss   16,345 20,828 44,043    
Total revenue   170,155 227,043 251,455    
SAFE            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Total revenue       11,000    
Genomatica, Inc. Preferred Stock            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
(Loss) gain on investments:   0 (11,885) (33,000)    
Impairment loss     11,900 33,000    
SAFEs            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
(Loss) gain on investments:     (7,208) (2,742)    
Impairment loss   (14,501) 7,200      
Non-marketable equity securities            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
(Loss) gain on investments:   (4,557) (1,735) (9,928)    
Impairment loss     $ 1,700 8,300    
Equity securities, downward price adjustment percentage     87.00%      
One Investment            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Impairment loss   1,800        
Escrow Shares | Circularis            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Contingent consideration, included in other non-current liabilities     $ 17,600      
Contingent consideration payment     $ 2,800      
Issuance of common stock for a business and asset acquisition (in shares) | shares     1,413,909      
Business combination, contingent consideration, vested value     $ 14,700      
Public Warrants            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Class of warrant or right, number of securities called by rights (in shares) | shares           34,500,000
Private Placement Warrants            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Class of warrant or right, number of securities called by rights (in shares) | shares           17,300,000
Fair Value, Inputs, Level 3            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Obligations, fair value       4,500    
Cell Engineering            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Financing receivable, excluding accrued interest, after allowance for credit loss $ 9,700 9,700 13,200      
Total revenue   $ 132,746 $ 173,972 $ 143,531    
Discount rate            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Equity securities, measurement input       0.14    
Discount rate | Cell Engineering            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Financing receivable, measurement input 0.155 0.155 0.155      
Minimum | Common Class A            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Class of warrant or right, number of securities called by rights (in shares) | shares           1
Minimum | Measurement Input, Scenario Probabilities            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Equity securities, measurement input       0.20    
Minimum | Measurement Input, Scenario Probabilities | Cell Engineering            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Financing receivable, measurement input 0.05 0.05 0.05      
Minimum | Measurement Input, Expected Term            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Equity securities, measurement input, term     1 year      
Maximum | Measurement Input, Scenario Probabilities            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Equity securities, measurement input       0.60    
Maximum | Measurement Input, Scenario Probabilities | Cell Engineering            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Financing receivable, measurement input 0.45 0.45 0.45      
Maximum | Measurement Input, Expected Term            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Equity securities, measurement input, term     2 years      
Maximum | Measurement Input, Expected Term | Cell Engineering            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Financing receivable, measurement input, period   5 months 2 years      
Senior Secured Note            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Financing receivable   $ 11,800 $ 11,800      
Financing receivable, interest rate 12.00% 12.00%        
Convertible Promissory Notes            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Conversion of notes receivable for common stock $ 1,500          
Debt conversion, converted instrument, shares issued (in shares) | shares 10,564